157 related articles for article (PubMed ID: 28528440)
21. The Promyelocytic Leukemia Protein facilitates human herpesvirus 6B chromosomal integration, immediate-early 1 protein multiSUMOylation and its localization at telomeres.
Collin V; Gravel A; Kaufer BB; Flamand L
PLoS Pathog; 2020 Jul; 16(7):e1008683. PubMed ID: 32658923
[TBL] [Abstract][Full Text] [Related]
22. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells.
Sourvinos G; Tavalai N; Berndt A; Spandidos DA; Stamminger T
J Virol; 2007 Sep; 81(18):10123-36. PubMed ID: 17626080
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein.
Kang H; Kim ET; Lee HR; Park JJ; Go YY; Choi CY; Ahn JH
J Gen Virol; 2006 Aug; 87(Pt 8):2181-2190. PubMed ID: 16847114
[TBL] [Abstract][Full Text] [Related]
24. Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies.
Scherer M; Read C; Neusser G; Kranz C; Kuderna AK; Müller R; Full F; Wörz S; Reichel A; Schilling EM; Walther P; Stamminger T
Elife; 2022 Mar; 11():. PubMed ID: 35319461
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections.
Tavalai N; Papior P; Rechter S; Leis M; Stamminger T
J Virol; 2006 Aug; 80(16):8006-18. PubMed ID: 16873257
[TBL] [Abstract][Full Text] [Related]
26. Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.
Bienkowska-Haba M; Luszczek W; Keiffer TR; Guion LGM; DiGiuseppe S; Scott RS; Sapp M
Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27860076
[TBL] [Abstract][Full Text] [Related]
27. PML and PML nuclear bodies: implications in antiviral defence.
Everett RD; Chelbi-Alix MK
Biochimie; 2007; 89(6-7):819-30. PubMed ID: 17343971
[TBL] [Abstract][Full Text] [Related]
28. MORC3 restricts human cytomegalovirus infection by suppressing the major immediate-early promoter activity.
Ma XH; Yao YX; Wang XZ; Zhou YP; Huang SN; Li D; Mei MJ; Wu JP; Pan YT; Cheng S; Jiang X; Sun JY; Zeng WB; Gong S; Cheng H; Luo MH; Yang B
J Med Virol; 2022 Nov; 94(11):5492-5506. PubMed ID: 35879101
[TBL] [Abstract][Full Text] [Related]
29. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
Adamson AL; Kenney S
J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
[TBL] [Abstract][Full Text] [Related]
30. Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.
Ueno T; Eizuru Y; Katano H; Kurata T; Sata T; Irie S; Ogawa-Goto K
Antimicrob Agents Chemother; 2006 Aug; 50(8):2806-13. PubMed ID: 16870775
[TBL] [Abstract][Full Text] [Related]
31. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
[TBL] [Abstract][Full Text] [Related]
32. Differential relocation and stability of PML-body components during productive human cytomegalovirus infection: detailed characterization by live-cell imaging.
Dimitropoulou P; Caswell R; McSharry BP; Greaves RF; Spandidos DA; Wilkinson GW; Sourvinos G
Eur J Cell Biol; 2010 Oct; 89(10):757-68. PubMed ID: 20599291
[TBL] [Abstract][Full Text] [Related]
33. Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells.
Seitz S; Heusel AT; Stamminger T; Scherer M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233232
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
35. Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.
Salsman J; Wang X; Frappier L
Virology; 2011 Jun; 414(2):119-29. PubMed ID: 21489587
[TBL] [Abstract][Full Text] [Related]
36. The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection.
Guion LG; Sapp M
Front Cell Infect Microbiol; 2020; 10():35. PubMed ID: 32154186
[TBL] [Abstract][Full Text] [Related]
37. Viruses as hijackers of PML nuclear bodies.
Möller A; Schmitz ML
Arch Immunol Ther Exp (Warsz); 2003; 51(5):295-300. PubMed ID: 14626429
[TBL] [Abstract][Full Text] [Related]
38. PML nuclear bodies and chromatin dynamics: catch me if you can!
Corpet A; Kleijwegt C; Roubille S; Juillard F; Jacquet K; Texier P; Lomonte P
Nucleic Acids Res; 2020 Dec; 48(21):11890-11912. PubMed ID: 33068409
[TBL] [Abstract][Full Text] [Related]
39. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
40. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
